Microfluidic Device Industry Growth PowerPoint PPT Presentations

The Global Microfluidic Device Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device industry.

According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market

Widefield Imaging Systems Market: Japan Regional Market Projected to Witness 2.1X Growth in Terms of Revenue over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

High number of research & development projects, increasing investments, and favorable regulatory policies are some other factors supporting growth of the market for pulmonary fibrosis treatment. Majority of the population living with pulmonary fibrosis is being treated with traditional corticosteroid combination drugs with limited efficacy. With the arrival of new novel therapies, unaddressed populations in middle- and lower-income countries, as well as developed countries, can offer significant revenue generation opportunities.

The microfluidics market is expected to witness market growth at a rate of 23.42% in the forecast period of 2022 to 2029. Data Bridge Market Research report on microfluidics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.

Global Microfluidic Devices Market size is projected to be valued $14 Billion by 2024; with a CAGR of 22.3% from 2017 to 2025. Microfluidics is an evolving scientific field with numerous analytical applications and commerci

Microfluidic Devices Market Share And Trends Analysis By Industry, Material, Application And Region - Forecast 2027

According to the latest research report by IMARC Group, The global biochips market size reached USD 22.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 76.0 Billion by 2033, exhibiting a growth rate (CAGR) of 13.02% during 2025-2033. More Info:- https://www.imarcgroup.com/biochips-market

The report Microfluidics Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Global microfluidic device demand outlook looks impressive for the years ahead, with the market expected to top US$ 21.5 Bn by the end of 2031. This industry survey by Persistence Market Research expects the microfluidic devices market to surge at a CAGR of around 24% over the forecast period of 2021-2031.

According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market

The global microfluidics market size reached US$ 20.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2027, exhibiting a CAGR of 16.47% during 2022-2027. More info:- https://www.imarcgroup.com/microfluidics-market

The Global And China Microfluidic Devices Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Devices industry.

According to the latest research report by IMARC Group, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market

Microfluidic devices are referred to as lithographic devices utilized for the diagnosis or analysis of small volumes of fluids to perform the chemical, physiological and biological procedures. Microfluidics devices are gaining popularity across extensive range of diagnostic applications because of need of extremely low quantity of samples and efficiency in data interpretation in comparison to the traditional laboratory equipment.

The Global And China Microfluidic Device Pumps Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device Pumps industry.

The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models.

The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.

Access Complete Report at - https://www.theinsightpartners.com/reports/perfusion-systems-market Perfusion Systems Market is expected to witness massive growth during the forecast period from 2019-2027, due to Significant Growth of Pharmaceutical and Biotechnology Industries. The Asia Pacific perfusion systems market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on perfusion systems. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.

Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 to 2024. Microfluidic involves flow of liquid within micro-sized channels.

The Microfluidic Devices Market Share is expected to reach USD 5,246.4 Million between 2021 at a CAGR of 22.8%.

The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Size – USD 20.14 Billion in 2021, Market Growth – at a CAGR of 16.1%, Market Trends – Increasing application of microfluidic platforms in various healthcare industries

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/

Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The Global Microfluidics Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. This report covers market landscape, strategies, merger & acquisition, size, key competitors, company profiles, progressive technological advancement, and expansion of production, segmentation, production, revenue and its growth prospects for the upcoming years.

Market Size – USD 9.51 billion in 2019, Market Growth - CAGR of 13.2%, Market Trends – Advancements in device technology.

The Business Research Company offers paper diagnostics market research report 2023 with industry size, share, segments and market growth

[258 Pages Report] Microfluidics Market categories the Global Market by Materials (Silicon, Polymers, Glass), Drug Delivery Devices (Microneedles, Micropumps), IVD (POC), Pharmaceuticals (Toxicity Screening, Microreactors, Proteomic & Genomic Analysis, Lab on Chip) & by Geography

Some of the key players operating in the piezoelectric ceramics market include KYOCERA Corporation (Japan), CeramTec GmbH (Germany), CTS Corporation (US), Murata Manufacturing Co., Ltd (Japan), TDK Corporation (Japan), Physik Instrumente (PI) GmbH & Co. (Germany), APC International, Ltd (US), L3Harris Technologies, Inc (US), HOERBIGER Motion Control GmbH (Germany), and Piezo Technologies (US).

The global market is in its growth phase, and is expected to witness significant growth rate of 63.2% during the forecast period, due to surge in applications of organ-on-chip devices in the healthcare sector and increase in demand for organ-on-chip in drug screening.

According to the latest research report by IMARC Group, The global PMMA microspheres market size reached US$ 356.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 803.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.16% during 2024-2032. More Info:- https://www.imarcgroup.com/pmma-microspheres-market

The biomedical industry, an evolving healthcare industry segment, can phenomenally revolutionize the healthcare device market. With the significant technological developments in surgical devices, implants, bioprinting, imaging methods, and much more, the biomedical industry is bridging the gap between biological science, medicine, and engineering. In an era of value-based delivery model, patients are now opting for treatments with minimally invasive procedures, which minimizes in-patient hospital stay and reduces healing time, thus reducing overall healthcare expenditure. For performing surgeries with the least incisions, such as pacemaker implantation, angioplasty, or smart drug delivery devices integration, among others; highly sophisticated devices loaded with various sensors & camcorders are a mandate. For more information, please visit below page and schedule a call with our experts@ https://www.iebrain.com/biomedical/

The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product.

[258 Pages Report] Microfluidics Market categories the Global Market by Materials (Silicon, Polymers, Glass), Drug Delivery Devices (Microneedles, Micropumps), IVD (POC), Pharmaceuticals (Toxicity Screening, Microreactors, Proteomic & Genomic Analysis, Lab on Chip) & by Geography

Molecular Diagnostics in Cancer Testing @ http://www.reportsnreports.com/reports/75216-molecular-diagnostics-in-cancer-testing.html The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.

Hyperbaric oxygen therapy (HBOT) devices are used for delivering pure oxygen (100%) to tissues in the body under higher atmospheric pressure. Atmospheric pressure in hyperbaric oxygen chambers or devices is increased from one to three times higher than normal atmospheric pressure which in turns fight bacteria and also stimulates the release of a substance called growth factors and stem cells promoting healing.

The global automated blood collection market size was USD 1.08 Billion in 2021 and is expected to register a revenue CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as growing public awareness about advantages that automated blood collection methods offer over manual blood collection techniques, ongoing demand for blood in hospitals, nursing homes, and ambulatory care facilities, rising rates of traffic accidents and trauma cases globally, and rising surgical rates.

World Synthetic Biology Market Was Valued At $ 5,245.7 Million In 2015 And Increasing Thereafter. rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in the market. Report Details Available @ http://www.bigmarketresearch.com/synthetic-biology-1520-market

Browse Complete Organ-On-Chips Global Opportunities And Strategies Market Report At: https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Global Micro-Electro-Mechanical Systems (MEMS)

Solid State Chemistry for Physics, Information Technology Devices and Energy Art Ramirez Director Device Physics Research Bell Labs SSC and Condensed Matter Physics ...

Lab-on-Chips Application Market Segmented By application in biotechnological and medical applications with technologies such as medical diagnostics, chemical synthesis and the study of complex cellular process

This report studies the global microfluidics market over the forecast period of 2013 to 2018.The global microfluidics market is valued at $1.59 billion in 2013 and is poised to reach $3.57 billion by 2018, at a CAGR of 17.6%.

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period.

The Global Lubricants Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. The microalgae market report includes extensive analysis of market drivers, restraints, market trends and competitive landscape across various geographies. The competitive landscape section includes all market deals of last 2 years of microalgae market. It includes new product launches, mergers and acquisitions, joint ventures, agreements etc.

The global microfluidic devices market size was estimated to be US$ 13 billion in 2019 and is expected to grow at a CAGR of 10.8% through 2030. Microfluidic devices have emerged as a convenient and efficient solution for high throughput and low volume analysis of biochemical fluids. The demand for microfluidic devices is primarily driven by the rising adoption of point-of-care devices for efficient and quick assessment of wide range of medical conditions.

Part 3 of 11 series: Entire part 1 to 11 can be viewed at https://issuu.com/newnatureparadigm/docs/0-water-tech-2016_june12 or https://www.scribd.com/doc/315759708/Four-Levels-of-Clean-Low-Cost-Underexplored-Water-Tech-for-Industrial-Commercial-Farming-applications Environmentally Friendly, Economical, Less Well Known Water Cleantech for The Future: Across industries and science fields, previously not accepted technologies, some of which has been widely used for commercialized applications, are gradually being re-confirmed by mainstream Western academics. The next phase is how Western mainstream media of various levels(from news, science reports, to Wikipedia) are going to express these confirmations.

Lab-On-a-Chip Market report segments global market by application, end-user, product, and technology – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025

Part 6 of 11 series: Entire part 1 to 11 can be viewed at https://issuu.com/newnatureparadigm/docs/0-water-tech-2016_june12 or https://www.scribd.com/doc/315759708/Four-Levels-of-Clean-Low-Cost-Underexplored-Water-Tech-for-Industrial-Commercial-Farming-applications Environmentally Friendly, Economical, Less Well Known Water Cleantech for The Future: Across industries and science fields, previously not accepted technologies, some of which has been widely used for commercialized applications, are gradually being re-confirmed by mainstream Western academics. The next phase is how Western mainstream media of various levels(from news, science reports, to Wikipedia) are going to express these confirmations.

BioMEMS devices deployed in hospitals and healthcare facilities are primarily focused on medical screening and diagnostic applications, such as devices that measure point-of-care parameters. Wearable devices that facilitate and assure continuous monitoring without hampering a user’s freedom of movement are being bolstered through new opportunities offered by innovative sensors for human biomedical signal acquisition coupled with wireless connectivity and low power solutions. In addition, greater attention is being accorded to diagnostic MEMS sensors that can assist in performing critical functions, such as cholesterol monitoring, pregnancy monitoring, food allergy detection and DNA analyses. Sensor technologies in several cases provide crucial outcomes and form a major element in the process of assisting in decision-making before obtaining formal clinical intervention and care.

The $65 billion US drug delivery system industry will continue to grow at an ... Biomedical engineers and physicians ... Oral and buccal drug delivery devices ...

The paper diagnostics Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of paper diagnostics.

BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery. Global BioMEMS and Microsystem Market in the Healthcare sector to grow at a CAGR of 25.1% over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/global-biomems-and-microsystem-in-healthcare-2015-2019-market

The growing incidence of cardiovascular diseases and the technological developments in interventional cardiology devices are driving the demand of the market.